Envision Pharma Group appoints Nick Marasco to Executive President & Chief Commercial Officer

Envision Pharma Group (Envision) today announces the appointment of Dominic (Nick) Marasco as Executive President & Chief Commercial Officer (CCO). Nick previously held the role of Chief Commercial Officer at Envision.

Nick is an experienced global commercial leader with nearly 30 years of pharmaceutical, biotech, and medical device industry experience. Having held several C-suite positions, he has a proven track record of successfully launching and growing products and solutions with a focus on driving profitable revenue growth, building, and leading high-performing commercial organizations.

In this role expansion, Nick will continue to lead Envision’s commercial-to-customer strategy with a focus on driving revenue growth, business expansion, and customer reach as the tech-enabled strategic solutions partner delivering smarter, faster outcomes for the life sciences industry.

Nick shares, “After joining Envision almost 10 months ago, it has become clear that the growth of Envision over many years has not slowed and the tremendous opportunity ahead of us has yet to be realized. I am excited to take on this expanded leadership role at Envision and look forward to the exciting future for our 1400+ employees around the globe.”

Howard Miller, Chief Executive Officer of Envision Pharma Group, adds, “I am excited for Nick to take on this expanded leadership role at Envision. His commercial expertise, exemplary leadership qualities, and strong customer focus will enable us to further advance our strategy and serve the needs of our customers through our tech-enabled strategic solutions.”

Connect with us

We can't wait to help and will be in touch as soon as possible.